The Critical Contribution of Pseudouridine to mRNA COVID-19 VaccinesPedro Morais, Yi‐Tao Yu|Frontiers in Cell and Developmental Biology|2021Cited by 264
Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendationsJesper Kammersgaard Christensen, Vibha Jawa, Guangnong Zhang et al.|Nucleic Acids Research|2025Cited by 12
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based ApproachesPedro Morais, Yi‐Tao Yu|Biomedicines|2024Cited by 8
Immunogenicity Risk Assessment for Nucleic Acid Therapeutics: A Comprehensive Evaluation for ASO, siRNA, and Nonvaccine mRNA/LNP Therapies by the IQ ConsortiumJoanna Grudzinska‐Goebel, Vibha Jawa, Linzhi Chen et al.|Nucleic Acid Therapeutics|2025Cited by 6